- Report
- January 2023
- 293 Pages
Global
From €3277EUR$3,600USD£2,783GBP
- Report
- January 2024
- 244 Pages
Global
€4546EUR$4,995USD£3,861GBP
- Clinical Trials
- September 2018
- 700 Pages
Global
From €2731EUR$3,000USD£2,319GBP
- Training
- 75 Minutes
Global
- Training
- 60 Minutes
Global
- Book
- April 2021
- 6032 Pages
€4061EUR$4,618USD£3,333GBP
- Book
- March 2021
- 320 Pages
- Book
- August 2018
- 816 Pages
Early Phase Studies are a critical part of the drug discovery process. They are the first step in the clinical development of a drug, and involve the testing of a drug's safety, efficacy, and pharmacokinetics in humans. Early Phase Studies are typically conducted in small groups of healthy volunteers or patients, and involve the administration of a single dose or multiple doses of the drug. The results of these studies are used to determine whether the drug is safe and effective for further clinical development.
Early Phase Studies are conducted by a variety of companies, including contract research organizations (CROs), pharmaceutical companies, and biotechnology companies. These companies provide services such as clinical trial design, data management, and regulatory support. They also provide expertise in drug development, clinical trial management, and regulatory compliance.
Some of the companies in the Early Phase Study market include Parexel, Quintiles, Covance, PPD, ICON, and Syneos Health. Show Less Read more